The Nevada Cannabis Compliance Board (CCB) has opened investigations into three dispensaries for promoting product that twice failed microbial testing.
On March 5, 2020, the Department of Taxation and CCB issued a directive to all dispensary/retail shops to right away cease promoting the product, Cherry OG F3, which failed laboratory testing for yeast and mildew, coliforms, Enterobacteriaceae and Aspergillus.
At that point, the CCB instructed dispensary/retail shops to destroy or return the affected product to the cultivator and talk that they took such motion with the State.
Despite the CCB’s directive, it seems three dispensaries retained their stock of Cherry OG and started promoting the product once more in May.
Approximately 375 grams of the Cherry OG product had been bought between May 19, 2020 and June 29, 2020 on the following Retail Stores/Medical Dispensaries:
Waveseer of Las Vegas, LLC (Jenny’s Dispensary), 5530 N Decatur Blvd, Las Vegas, NV 89130 (License # 83760475147127946601);
Paradise Wellness Center, LLC (Las Vegas ReLeaf), 2244 Paradise Road, Las Vegas, NV 89104 (License # 54283805068313943868); and
Desert Aire Wellness, LLC (Sahara Wellness), 420 E Sahara Ave, Las Vegas, NV 89104 (License # 25729455103203031356)
On May 16, 2020, a maintain on the product was briefly lifted as a consequence of a CCB error that occurred throughout an unrelated investigation. However, the CCB’s well being and security advisory remained in impact; and underneath the directive, dispensaries shouldn’t have had the product of their stock.
The CCB advises those that have bought the product to keep away from consuming it. Consumers ought to test any Cherry OG merchandise for the supply package deal #1A404030000076F000006649. The CCB notified the aforementioned dispensaries and initiated investigations that are ongoing. There aren’t any identified experiences of sickness.